Subchronic toxicity of cannabis leaves on male albino rats

Human and Experimental Toxicology

Volumn 29, Issue 1, 2010, Pages 37-47

  Yassa, Heba A ^a   Dawood, Abd El Wahab A ^a   Shehata, Manal M ^a   Abdel Hady, Randa H ^a   Abdel Aal, Khaled M ^a  

^a ASSIUT UNIVERSITY   (Egypt)

Author keywords

Bango; Cannabis leaves; Lethal dose 50

Indexed keywords

CANNABIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CHRONIC TOXICITY; CONTROLLED STUDY; CYTOPLASM; HISTOPATHOLOGY; KIDNEY; LD 50; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPERMATOCYTE; TESTIS;

ANIMALS; BRAIN; CANNABIS; KIDNEY; LETHAL DOSE 50; LIVER; MALE; NEURONS; ORGAN SIZE; PLANT EXTRACTS; PLANT LEAVES; RANDOM ALLOCATION; RATS; RATS, WISTAR; TESTIS;

ANIMALIA; CANNABIS; RATTUS;

EID: 74849107198     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327109354312     Document Type: Article

References (32)

1. Guxens M., Nebot M., Ariza C., Ochoa D. Factors associated with the onset of cannabis use: a systematic review of cohort studies. Gac Saint 2007 ; 21: 252-260.
2. Alvarez FJ, Fierro I., Del R o MC Cannabis and driving: results from a general population survey. J Forensic Sci Int 2007 ; 170: 111-116.
3. Interpol Drug Substances Directorate. Drug abuse. www.Interpol.int/ public/Drugs/cannabis.asp ( 2006, accessed May 2006 ).
4. El Akabawi AS Drug abuse in the Arab world: a country profile of Egypt. World Psych Association Series 2001 ; 3: 143-115.
5. Abdel Gawad S. Facets of drug abuse in Egypt: An overview. E-journal of the International Society of Addiction. www.ucalgary.ca/uafc/department/UP/ journals.com (accessed April 2006 ).
6. Frank M., Rosenthal E. Cannabis and ancient history. In: Frank M., Wiliams O, and Kallan L. Marijuana Growers Guide. 2 nd edition. Chapter 1. Framington hills 1978, p. 3-10.
7. Macphee D. Effects of marijuana on cell nuclei: a review of the literature relating to the genotoxicity of cannabis. In: Kalant H, Corrigal W, Hall W, Smart R (eds.). The Health Effects of Cannabis. 1stedn. Chap. 8. Toronto Center for Addiction and Mental Health. 1999, p. 293-230.
8. Huestis M. Cannabis effects on human behavior and performance. J Forensic Sci Rev 2002 ; 14: 1-25.
9. Zimmer L., and Morgan J. Route of administration of cannabis. In: Zimmer L., and Morgan J. Marijuana Facts: a review of scientific evidence. 2 nd edition. Chapter 3. New York: Lindesmith Center, 1997, p. 90-97.
10. Elwan O., Hassan A., Nasser M., et al. Brain aging in a sample of normal Egyptians cognition, education, addiction and smoking. J Neurological Sci 1997 ; 148: 79-86.
11. Hezode C., Thoraval F., Nguyen S., et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 2005 ; 42: 63-71.
12. Lambrecht N. Marijuana smoking associated with kidney damage. Publication of Drug Watch Oregan 1996 ; 3: 1-3.
13. Sigman M., Howards S. Male infertility. In: Walsh P (ed.) Campbells urology. 7 th ed. Chap. 10. Philadelphia: Saunders, 1998, p. 1287-1300.
14. Fadda P., Robinson L., Fratta W., Pertwee R., Riedel G. Differential effects of THC or CBD rich cannabis extracts on working memory in rats. Neuropharmacology 2004 ; 47: 1170-1179.
15. Singh M., McGregor I., Mallet P. Perinatal exposure to "9 tetrahydrocannabinol alters heroin induced place conditioning and Immunoreactivity. Neuropsychopharmacology 2006 ; 31: 58-69.
16. Bianchi V., Donazelli G. Rapid reversed phase high performance liquid chromatographic method for the assay of urinary 11- nor "9 tetrahydrocannabinol -9 carboxylic acid and confirmation of use of cannabis derivatives. J Chromatogr B 1996 ; 675: 162-167.
17. Hammond AC Animal well-being in pharmacology and toxicology research. J Anim Sci. 1994 ; 72: 523-527.
18. Gad S., Weil C. Statistics for toxicologists. In Hayes A (ed.) Principles and methods of toxicology. 2 nd ed. Chap. 15. New York: Raven Press, 1989, p. 435-479.
19. www.epa.gov/oppfead1/harmonization.com
20. Shivprakash C. A computer program for calculation of LD50. Indian Journal of Pharmacology 1995 ; 27: 253-257.
21. Chopra S., Soni R., Chopra A. A computer program for determination of LD50 using Dbase/Foxpro. Indian Journal of Pharmacology 2000 ; 32: 390-391.
22. Shiojiri N. Analysis of differentiation of hepatocytes and bile duct cells in developing mouse liver by albumin immunofluorescence. Develop Growth Differ 1984 ; 26: 555-561.
23. Iversen L. Cannabis and the brain. Brain 2003 ; 126: 1252-1270.
24. Downer EJ, Gowran A., Murphy AC, Campbell VA The tumor suppressor protein, p53, is involved in the activation of the apoptotic cascade by Delta9-tetrahydrocannabinol in cultured cortical neurons. Eur J Pharmacol 2007 ; 564: p. 57-65.
25. Snchez C., Galve-Roperh I., Canova C., Brachet P., Guzmn M. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett 1998 ; 436 :p. 6-10.
26. Zimmerman H. Vulnerability of the liver to toxic agents. In: Hepatotoxicity: the adverse effects of drugs. 2 nd ed. Chap. 3. Philadelphia: Lippicott Williams and Wilkins, 1995, p. 41-81.
27. Barini P., Cardoso R., Bicalho S. Possible hepatotoxicity of chronic marijuana usage. Soo Paulo Med J 1995 ; 122 ; p. 110-116.
28. Atici S., Cinel I., Cinel L., Doruk N., Eskandare G., Oral U. Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model. J Biosci 2005 ; 30: p. 254-252.
29. Athanasiou A., Clarke A., Turner A., et al. Cannabinoid receptor agonists are mitochondrial inhibitors: A unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun 2007 ; 364: 131-137.
30. Gye M., Kang H., Kang H. Expression of cannabinoid receptor in mouse testis. Arch Androl 2005 ; 51: 147-155.
31. Pardo G., Legua V., Remohi J., Bonilla musoles F. Review and uptake: marijuana and reproduction. Acta Ginecol 1985 ; 42: 420-429.
32. Rubino T., Vigano D., Realini N., et al. Chronic delta 9 tetrahydrocannabinol during adolesece provokes sex dependent changes in the emotional profile in adult rats. Behav Biochem Correlates Neuropsychopharmacology 2008 ; 33: 2760-2771.